Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Compounded Medications Recalled
07/29/2021
Jolynn Tumolo
Following a routine inspection of the pharmacy by the FDA, Innoveix Pharmaceuticals Inc initiated voluntary recalls of the compounded drug products AOD-9604 3 mg and sermorelin/ipamorelin 3 mg.
Following a routine inspection of the pharmacy by the FDA, Innoveix Pharmaceuticals Inc initiated voluntary recalls of the compounded drug products AOD-9604 3 mg and sermorelin/ipamorelin 3 mg.
Following a routine inspection...
07/29/2021
Pharmacy Learning Network
News
Topical Antibiotic Recalled
07/29/2021
Jolynn Tumolo
A recall is active for a prescription macrolide antibiotic used to treat certain eye infections as well as to prevent them in newborns.
A recall is active for a prescription macrolide antibiotic used to treat certain eye infections as well as to prevent them in newborns.
A recall is active for a...
07/29/2021
Pharmacy Learning Network
News
OTC Pain Reliever Recalled Over Labeling Error
07/29/2021
Jolynn Tumolo
The FDA has issued a recall for an over-the-counter medication used to treat mild to moderate pain and reduce fever.
The FDA has issued a recall for an over-the-counter medication used to treat mild to moderate pain and reduce fever.
The FDA has issued a recall for...
07/29/2021
Pharmacy Learning Network

Advertisement

News
Newer Generation Pharmacy Students Increasingly Prioritizing Self-Care, Individual Goals
07/22/2021
Maria Asimopoulos
Postmillennial pharmacy students identified life priorities more geared toward self-care and personal growth than those of previous generations, supporting the modernization of student support mechanisms.
Postmillennial pharmacy students identified life priorities more geared toward self-care and personal growth than those of previous generations, supporting the modernization of student support mechanisms.
Postmillennial pharmacy students...
07/22/2021
Pharmacy Learning Network
News
Chemotherapy Agent Recalled
07/16/2021
Jolynn Tumolo
The FDA is recalling a chemotherapy injection used to treat cancer of the ovary, lung, and cervix.
The FDA is recalling a chemotherapy injection used to treat cancer of the ovary, lung, and cervix.
The FDA is recalling a...
07/16/2021
Pharmacy Learning Network
News
Opioid Dependence Drug Recalled for Subpotency
07/16/2021
Jolynn Tumolo
Alvogen Inc is recalling a single lot of buprenorphine and naloxone sublingual films because of subpotency.
Alvogen Inc is recalling a single lot of buprenorphine and naloxone sublingual films because of subpotency.
Alvogen Inc is recalling a...
07/16/2021
Pharmacy Learning Network

Advertisement

News
Over 88,000 Anti-Inflammatory Injections Recalled
07/16/2021
Jolynn Tumolo
A Class II recall is active for a prescription anti-inflammatory injection used to treat asthma, nasal polyps, and chronic idiopathic urticaria.
A Class II recall is active for a prescription anti-inflammatory injection used to treat asthma, nasal polyps, and chronic idiopathic urticaria.
A Class II recall is active for...
07/16/2021
Pharmacy Learning Network
News
FDA Approves Monoclonal Antibody for Use in Combination Treatment for Multiple Myeloma
07/13/2021
Maria Asimopoulos
"With this approval, we are now able to combine pomalidomide and dexamethasone with a daratumumab subcutaneous option that can be administered in minutes rather than the hours needed for intravenous administration,” said Meletios A...
"With this approval, we are now able to combine pomalidomide and dexamethasone with a daratumumab subcutaneous option that can be administered in minutes rather than the hours needed for intravenous administration,” said Meletios A...
"With this approval, we are now...
07/13/2021
Pharmacy Learning Network
News
FDA Updates Biogen Alzheimer Drug Indications
07/08/2021
Maria Asimopoulos
“… we submitted this label update with the goal to further clarify the patient population that was studied across the three ADUHELM clinical trials that supported approval,” said Alfred Sandrock Jr, MD, PhD, head of research and development...
“… we submitted this label update with the goal to further clarify the patient population that was studied across the three ADUHELM clinical trials that supported approval,” said Alfred Sandrock Jr, MD, PhD, head of research and development...
“… we submitted this label...
07/08/2021
Pharmacy Learning Network

Advertisement

News
Examining Diversity Among Ambulatory Care Pharmacists in Underserved Areas
07/07/2021
Jolynn Tumolo
“With a large majority of our respondents identifying as White and unilingual, there remains a large opportunity to increase diversity in the clinical pharmacy ambulatory care workforce caring for underserved populations,” researchers wrote.
“With a large majority of our respondents identifying as White and unilingual, there remains a large opportunity to increase diversity in the clinical pharmacy ambulatory care workforce caring for underserved populations,” researchers wrote.
“With a large majority of our...
07/07/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use